Login / Signup

14-CpG-Based Signature Improves the Prognosis Prediction of Hepatocellular Carcinoma Patients.

Hong-Ye JiangGang NingYen-Sheng WangWei-Biao Lv
Published in: BioMed research international (2020)
The 14-CpG-based signature is significantly associated with OS and may be used as a novel prognostic biomarker for HCC patients.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • dna methylation
  • prognostic factors